Devoted to the Pursuit of Clinical Excellence in Gastroenterology and Hepatology for Over 30 Years
AGENDA
FRIDAY, MAY 15, 2026
APP Bootcamp
This bootcamp will provide an overview of the updated nomenclature and definitions of MASLD/MASH, including epidemiology, natural history, and key metabolic risk factors associated with disease progression. Participants will learn current approaches to diagnosis and risk stratification, with a focus on utilizing and interpreting noninvasive fibrosis assessment tools such as FIB-4 and elastography, and identifying patients who may benefit from hepatology referral. The bootcamp will also cover evidence-based lifestyle interventions and emerging pharmacologic therapies, including resmetirom and GLP-1 receptor agonists, with an emphasis on patient counseling, treatment selection, monitoring, and integration into comprehensive disease management.
Accredited by Medical Education Resources. Supported by an educational grant from Madrigal Pharmaceuticals.
1:00–2:00 PM Spyglass Foyer
Registration and Lunch*
2:00–2:10 PM Spyglass 1-2
Program Overview
APP Co-Chairs:
Nia Maninang, NP- Stanford Health Care
Shraddha Batra, PA-C- Kaiser Permanente, South San Francisco
2:10–2:30 PM Spyglass 1-2
Session 1: Understanding MASH: A Practical Overview for APPs
Maribel Torres, NP- Adventist Health Central Valley
2:30–3:00 PM Spyglass 1-2
Session 2: Diagnosis and Risk Stratification of MASH
Francisco Debs, PA- Santa Maria Gastroenterology
3:00–3:15 PM Spyglass 1-2
Session 3: Lifestyle Interventions for MASLD
Reena Gupta, NP- Kaiser Permanente, Oakland
3:15–3:35 PM Spyglass 1-2
Session 4: Pharmacologic & Non-Pharmacologic Treatment of MASH
Sara Miller, NP- University of California, San Francisco
3:35–4:00 PM Spyglass 1-2
Q&A Session
4:00–4:30 PM Spyglass Foyer
Break*
4:30 –5:15 PM Spyglass 1-2
APP Discussion*
Participants will engage in small-group breakout discussions focused on professional development, collaboration, and shared clinical experiences among gastroenterology and hepatology APPs. Topics may include clinical workflow, scope of practice, patient education
strategies, and career development within GI/hepatology.
5:15–6:00 PM Spyglass 1-2
Reassessing the Adult Patient with Complex Cholestasis
Speaker: Beshoy Yanny, MD- University of California, Irvine
Industry-Sponsored Event*
Sponsored by Ipsen Biopharmaceuticals
6:30 PM Regency Main 1-3
Conference Welcome Reception*
SATURDAY, MAY 16, 2026
7:15–7:45 AM Regency Foyer & Main 1-3
Breakfast, Registration, and Visit Exhibits/Posters *
7:45–8:30 AM Regency Main 4-6
Tremfya® for the Treatment of Adult Patients with Moderately to Severely Active Crohn's Disease
Ryan McConnell, MD — Palo Alto Foundation Medical Group
Industry-Sponsored Event*
Sponsored by Johnson & Johnson
SESSION 1 Regency Main 4-6
9:00–9:10 AM
Day 1 — Program Overview
Christina Chou, MD — Alameda Health System
9:10–9:40 AM
Colon Cancer Screening: Scope, Stool or Serum?
Theodore Levin, MD — Kaiser Permanente
9:40–10:00 AM
Advanced Endoscopy
Drew Schembre, MD — John Muir Health
10:00–10:15 AM
Panel Discussion / Q&A
10:15–10:40 AM Regency Foyer & Main 1-3
Break and Visit Exhibits/Posters*
SESSION 2 Regency Main 4-6
10:40–11:00 AM
Ten Mistakes to Avoid in Managing Patients With Diverticular Disease
Neil Stollman, MD — East Bay Center for Digestive Health
11:00–11:20 AM
Liver Year in Review
Kidist Yimam, MD — CPMC
11:20–11:35 AM
Panel Discussion / Q&A
11:35 AM–12:05 PM
Top 10 Things All Clinicians Should Know About Celiac Disease in 2026
Keynote Speaker: Amy Oxentenko, MD — Mayo Clinic - Rochester
12:05–12:15 PM
Keynote Q&A
12:15–12:25 PM
Awards
12:25–12:45 PM Regency Foyer & Main 1-3
Lunch and Visit Exhibits/Posters*
12:45–1:30 PM Regency Main 4-6
Transform the Way You Manage Eosinophilic Esophagitis (EoE) - The First and Only FDA-Approved Treatment for EoE Patients As Young As 1 Year
Quan Nhu, MD, PhD- Scripps Clinic
Industry-Sponsored Event*
Sponsored by Regeneron
1:30–2:30 PM Regency Foyer
Ice Cream Social & Networking
APPs & Trainees
4:30–6:00 PM Regency Main 4-6
Social Hour — GI Janes & Allies Clinical Exchange Reception
SUNDAY, MAY 17, 2026
7:15–7:45 AM Regency Foyer & Main 1-3
Breakfast and Visit Exhibits/Posters*
7:45–8:30 AM Regency Main 4-6
Industry-Sponsored Event*
Beshoy Yanny, MD- University of California, Irvine
Evolving Approach to Second-Line Treatment in PBC
Sponsored by Ipsen Biopharmaceuticals
SESSION 3 Regency Main 4-6
9:00–9:05 AM
Day 2 — Program Overview
9:05–9:35 AM
Complicated Cases in IBD
Eric Mao, MD — UC Davis Medical Center
Sundeep Singh, MD — Stanford University
9:35–9:55 AM
Management of Refractory Bloating
Irene Sonu, MD — Stanford University
9:55–10:15 AM
Applications of Generative AI in Gastroenterology and Hepatology
Jin Ge, MD — University of California, San Francisco
10:15–10:35 AM
Panel Discussion / Q&A
10:35–10:50 AM Regency Foyer & Main 1-3
Break and Visit Exhibits/Posters*
SESSION 4 Regency Main 4-6
10:50–11:35 AM
Clinical Management of Gastrointestinal Disorders in Pregnancy: Current Recommendations
Christina Chou, MD — Alameda Health System
11:35–11:55 AM
Transition/Transfer of Care from Pediatrics to Adulthood
Sabina Ali, MD — University of California, San Francisco
11:55 AM–12:15 PM
Panel Discussion / Q&A
12:15 PM
Adjournment*
*Non-accredited session